共 17 条
[1]
The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics. Jonathan C,Ratko D,Lynette T,et al. The Journal of Clinical Investigation . 1997
[2]
Effect of anti-IgE therapy in patients with peanut allergy. Leung D Y,Sampson HA,Yunginger JW,et al. The New England Journal of Medicine . 2003
[3]
Omalizumab (Xolair) improves quality of life in adult patients with allergic asthma: a review. Buhl R. Respiratory Medicine . 2003
[4]
l Omalizumab,a novelanti-IgE therapy in allergic d isorders. Babu KS,Arshad SH,Holgate ST,et a. ExpertOp in B iolTher . 2001
[5]
Is there a role for treatment of asthma with omalizumab. Milgrom H. Archives of Disease in Childhood . 2003
[6]
Therapy of allergic bronchial asthma with omalizumab: antiIgE monoclonal antibody. Gennnaro DA. Expert Opinion on Biological Therapy . 2003
[7]
Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders. Schulman ES. American Journal of Respiratory and Critical Care Medicine . 2001
[8]
The anti-IgE/anti-FcεRIα autoantibody network in allergic and autoimmune diseases. Marone G,Spadaro G,Palumbo C,et al. Clinical and Experimental Allergy . 1999
[9]
Molecular Basis for Nonanaphylactogenicity of a Monoclonal anti-IgE Antibody. Michael PR,Adrian WZ,Andreas N,et al. J Immunol . 2000
[10]
PROTEIN ENGINEERING[P]. 英国专利:GB9311328D0,1993-07-21